Riverhead Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $888K | Hold |
2,668
| – | – | 0.03% | 524 |
|
|
2019
Q2 | $834K | Hold |
2,668
| – | – | 0.03% | 547 |
|
|
2019
Q1 | $816K | Sell |
2,668
-500
| -16% | -$153K | 0.03% | 523 |
|
|
2018
Q4 | $736K | Sell |
3,168
-100
| -3% | -$23.2K | 0.03% | 531 |
|
|
2018
Q3 | $1.02M | Buy |
3,268
+1,000
| +44% | +$313K | 0.04% | 481 |
|
|
2018
Q2 | $654K | Hold |
2,268
| – | – | 0.03% | 586 |
|
|
2018
Q1 | $567K | Hold |
2,268
| – | – | 0.02% | 608 |
|
|
2017
Q4 | $541K | Buy |
2,268
+300
| +15% | +$71.6K | 0.02% | 630 |
|
|
2017
Q3 | $437K | Buy |
1,968
+169
| +9% | +$37.5K | 0.02% | 654 |
|
|
2017
Q2 | $407K | Buy |
1,799
+799
| +80% | +$181K | 0.02% | 669 |
|
|
2017
Q1 | $199K | Buy |
1,000
+100
| +11% | +$19.9K | 0.01% | 773 |
|
|
2016
Q4 | $164K | Buy |
900
+100
| +13% | +$18.2K | 0.01% | 782 |
|
|
2016
Q3 | $131K | Sell |
800
-828
| -51% | -$136K | 0.01% | 804 |
|
|
2016
Q2 | $233K | Sell |
1,628
-1,998
| -55% | -$286K | 0.01% | 831 |
|
|
2016
Q1 | $496K | Sell |
3,626
-74
| -2% | -$10.1K | 0.01% | 884 |
|
|
2015
Q4 | $513K | Buy |
3,700
+2,800
| +311% | +$388K | 0.01% | 884 |
|
|
2015
Q3 | $121K | Buy |
+900
| New | +$121K | ﹤0.01% | 980 |
|